Talk:Richard Scolyer

Connected contributor

I am requesting edits for Prof Richard Scolyer AO, Co-Medical Director of Melanoma Institute Australia. I am an employee of Melanoma Institute Australia. Mia Varley (talk) 09:57, 12 January 2021 (UTC)

Request for edit - Update to introduction

In intro please add the text in bold so that faculty is included:

Richard Scolyer is an Australian pathologist who is Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; Co- Medical Director, Melanoma Institute Australia;[1] and Conjoint Professor, Faculty of Medicine and Health, Sydney Medical School, The University of Sydney.[2]

Mia Varley (talk) 10:08, 12 January 2021 (UTC)

 Not done: Excessive title - intro of an article is supposed to provide a high-level description of the subject. 15 (talk) 18:34, 17 April 2021 (UTC)

Request for edit - Update to 'Career' section

Please update sections that are bold. These changes allow the content to read better and are updates to number of citations, new awards etc:

Prof Scolyer provides a clinical consultation service for the diagnosis of difficult pigmented lesions and receives more than 2000 cases for opinion from Australasia and beyond annually. He effectively integrates his clinical practice with leading an award winning translational melanoma research laboratory.[1]

Scolyer has co-authored more than 700 peer reviewed publications/book-chapters including in journals New England Journal of Medicine, Lancet, Nature, Cell, Nature Genetics, Lancet Oncology, Journal of Clinical Oncology, Journal of the National Cancer Institute and Cancer Discovery with more than >43,000 citations and a h-index of 105 . Scolyer has presented on more than 370 occasions at conferences throughout the world.[1]

In 2020, he received the Cancer Institute NSW Premier's Award – Outstanding Cancer Researcher of the Year, the Royal College of Pathologists of Australasia (RCPA) Distinguished Fellow Award 2020, The University of Sydney's 2020 International Alumni Award and Clarivate Web of Science Group “Highly Cited Researcher 2020”. He received a NSW Premier's Award for Outstanding Cancer Research in 2009, 2012, 2013, 2014, 2016, 2017 and 2018,[3] Thomson Reuters 2015 Citation Award in the Clinical Medicine category, the 2018 William O. Russell/Joanne Vandenberge Hill Award for Lifetime Achievement in Anatomical Pathology, MD Anderson Cancer Center, Research Australia's 2018 GSK Award for Research Excellence and the 2019 American Society of Dermatopathology's Elson B Helwig Award for excellence in dermatopathology[4]. === PLEASE DELETE THIS BOLD SECTION AS MOVED TO EARLIER IN PARAGRAPH:<<and The University of Sydney's 2020 International Alumni Award.[5] His publications have received most highly cited awards on 5 other occasions. Recently, Scolyer was recognised as a Clarivate Web of Science “Highly Cited Researcher 2019”.[6]DELETE TO HERE>> ==== According to Thomson Reuters ISI Web of Knowledge, Scolyer is the highest ever published scientist in the world in the field of melanoma pathology and he also has the highest h-index in this field.[7] The Fame Report (2011) published by Medical Experts International ranked him the 6th leading melanoma expert in any field or discipline worldwide and the highest ranked melanoma pathologist worldwide. In October 2020 he was ranked the world's 7th leading melanoma expert in any field or discipline and the world's leading melanoma pathologist.[8] In September 2019, Scolyer was ranked as the leading Australian Pathologist in the entire field of Pathology.[9] In July 2020, he was selected as a finalist for The Pathologist's 2020 Power List within the “Big Breakthroughs” category, which celebrates trailblazers working at the cutting edge and driving onward the future of the field.[10]

No edits required to last 2 paragraphs.

Mia Varley (talk) 11:00, 12 January 2021 (UTC)

 Not done Request consists almost entirely in promotional material. Current status quo does not contain most of the original statements that editor requests to be amended. JBchrch talk 16:00, 28 June 2021 (UTC)

Request edit - Update to Awards section

Awards

2020- The Royal College of Pathologists of Australasia (RCPA) Distinguished Fellow Award 2020 The award, the highest that the College has to bestow, is made in recognition of eminent position as one of Australia’s most distinguished medical researchers, far-reaching consultative practice for melanomas and skin cancers and improvement in diagnoses and treatment, membership and contributions on international committees and mentoring of young colleagues.

2020 - Clarivate Web of Science Group “Highly Cited Researcher 2020” .

2020 - The Pathologist’s 2020 Power List within the “Big Breakthroughs” category

2020 - The University of Sydney’s 2020 Alumni Award for International Achievement.

2019 - Clarivate Web of Science Group “Highly Cited Researcher 2019”.

2019 - The Pathologist’s 2019 “Trailblazers” Power List – a power list of top 100 Pathologists worldwide with RS listed in top 10 and the only Australian in the top 100.

2018 - NSW Premier's ‘Professor Rob Sutherland AO Make a Difference Award” awarded to RA Scolyer.

2018 - Research Australia’s 2018 GSK Award for Research Excellence Co-Awarded Professor Richard Scolyer and Professor Georgina Long.

2018 - William O. Russell Lectureship and Joanne Vandenberge Hill Award for Lifetime Achievement in Anatomical Pathology, MD Anderson Cancer Centre

2017 - NSW Premier’s Awards for Outstanding Cancer Research: Wildfire Award for most highly cited paper in a peer reviewed journal. BRAF Inhibitor Resistance Mechanisms in Metastatic Melanoma: Spectrum and Clinical Impact. Clin Cancer Res. 2014 Apr 1;20(7):1965-77.

2017 - NSW Premier's Awards 'Excellence in Translational Cancer Research'. Co-awarded to Scolyer RA and Long GV.

2016 - Royal Prince Alfred Hospital Foundation Research Medal and Prize.

2016 - Cancer Institute NSW Premiers Awards: Wildfire Award, most cited article published in 2013: Long GV, Wilmott JS, Capper D, Preusser M, Zhang YE, Thompson JF, Kefford RF, von Deimling A, Scolyer RA., Am J Surg Pathol 2013

2015 - Winner Thomson Reuters Citation and Innovation Award for outstanding research team. For research in BRAF-mutated melanoma. Co-winners with Professor Georgina Long, Professor Richard Kefford, Professor Grant McArthur.

2014 - Premier’s Awards for Outstanding Cancer Research: Wildfire Award for most cited article published in a peer reviewed journal. Long GV, Menzies AM, Nagrial AM, Haydu L, Hamilton AL, Mann GJ, Hughes TM, Thompson JF, Scolyer RA, Kefford, RF. “Prognostic and clinico-pathologic associations of oncogenic BRAF in metastatic melanoma.” J Clin Onc 2011

2013 -NSW Premier’s Awards for Outstanding Cancer Research: Wildfire Award for most highly cited paper in a peer reviewed journal. Guitera P, Pellacani G, Crotty KA, Scolyer RA, Li L-XL, Bassoli S, Vinceti M, Rabinovitz H, Longo C, Menzies SW. ‘The Impact of In Vivo Reflectance Confocal Microscopy on the Diagnostic Accuracy of Lentigo Maligna and Equivocal Pigmented and Nonpigmented Macules of the Face.’ J Invest Dermatol 2010

2012 - Premier's Awards for Outstanding Cancer Research: Outstanding Cancer Research Fellow.

2009 - Premier's Awards for Outstanding Cancer Research: Outstanding Cancer Research Fellow, 2009

2009 - Premier's Award for Excellence in Translational Research: Sydney Melanoma Unit (CINSW Translational Program Grant CIs: Mann, Thompson, Kefford, Scolyer, Hersey, Menzies, Christopherson)

References

Mia Varley (talk) 06:59, 19 January 2021 (UTC)

 Not done. Per WP:NOTCV. Awards that are sourced to secondary sources might be included. JBchrch talk 15:54, 28 June 2021 (UTC)

Glioblastoma treatment

I have added more on Dr Scolyer's glioblastoma treatment based on [1]. However, I am not from the medical field (I came across this via unfortunate personal layman interest in glioblastoma treatments given a colleague died of it a few months ago) and so encourage any corrections where I and/or the BBC (the source I used) may be wrong or oversimplifying. I note there is a connected contributor, @Mia Varley:, who is most correctly editing only this talk page and not the article itself. If you or others care to suggest changes for accuracy, I am happy to review for connected bias (unlikely) and transfer over. Thanks Martinp (talk) 11:05, 3 February 2024 (UTC)

Updated to say ten

I haven't updated the citations. See RS's Twitter profile. Svennik (talk) 10:00, 23 March 2024 (UTC)